JP MORGAN/CALL/BECTON DICKINSON AND CO./285/0.1/21.06.24 Share Price

Warrant

DE000JB0XYP7

Market Closed - Börse Stuttgart 07:41:11 21/05/2024 BST
0.002 EUR 0.00% Intraday chart for JP MORGAN/CALL/BECTON DICKINSON AND CO./285/0.1/21.06.24
Current month-94.59%
1 month-94.12%
Date Price Change
21/05/24 0.002 0.00%
20/05/24 0.002 -33.33%
17/05/24 0.003 -40.00%
16/05/24 0.005 -44.44%
15/05/24 0.009 +12.50%

Delayed Quote Börse Stuttgart

Last update May 21, 2024 at 07:41 am

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying BECTON, DICKINSON AND COMPANY
Issuer J.P. Morgan
WKN JB0XYP
ISINDE000JB0XYP7
Date issued 22/08/2023
Strike 285 $
Maturity 21/06/2024 (31 Days)
Parity 10 : 1
Emission price 1.95
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 3.57
Lowest since issue 0.002
Spread 0.699
Spread %99.86%

Company Profile

Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical equipment (73.5%): surgical instruments, urological care products, pharmaceutical systems, etc.; - diagnostic materials (18.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, etc.; - clinical research and development tools (7.8%): tools for discovering drugs and vaccines, studying genes, culturing cells, and manipulating liquids, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (57.4%), Europe/Middle East/Africa (21.9%), Asia (15%) and other (5.7%).
Sector
-
More about the company

Ratings for Becton, Dickinson and Company

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Becton, Dickinson and Company

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
234.9 USD
Average target price
279 USD
Spread / Average Target
+18.79%
Consensus